4D Molecular Therapeutics Statistics
Total Valuation
FDMT has a market cap or net worth of $449.58 million. The enterprise value is $12.48 million.
Important Dates
The last earnings date was Thursday, May 7, 2026, after market close.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
FDMT has 52.28 million shares outstanding. The number of shares has increased by 9.81% in one year.
| Current Share Class | 52.28M |
| Shares Outstanding | 52.28M |
| Shares Change (YoY) | +9.81% |
| Shares Change (QoQ) | +6.49% |
| Owned by Insiders (%) | 3.55% |
| Owned by Institutions (%) | 81.35% |
| Float | 38.84M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.09 |
| Forward PS | 32.13 |
| PB Ratio | 0.99 |
| P/TBV Ratio | 1.00 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.14 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.34, with a Debt / Equity ratio of 0.05.
| Current Ratio | 9.34 |
| Quick Ratio | 9.01 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -34.92% and return on invested capital (ROIC) is -22.82%.
| Return on Equity (ROE) | -34.92% |
| Return on Assets (ROA) | -21.43% |
| Return on Invested Capital (ROIC) | -22.82% |
| Return on Capital Employed (ROCE) | -37.56% |
| Weighted Average Cost of Capital (WACC) | 18.57% |
| Revenue Per Employee | $450,214 |
| Profits Per Employee | -$820,903 |
| Employee Count | 196 |
| Asset Turnover | 0.17 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +142.25% in the last 52 weeks. The beta is 2.76, so FDMT's price volatility has been higher than the market average.
| Beta (5Y) | 2.76 |
| 52-Week Price Change | +142.25% |
| 50-Day Moving Average | 9.47 |
| 200-Day Moving Average | 9.00 |
| Relative Strength Index (RSI) | 40.91 |
| Average Volume (20 Days) | 657,380 |
Short Selling Information
The latest short interest is 11.99 million, so 22.94% of the outstanding shares have been sold short.
| Short Interest | 11.99M |
| Short Previous Month | 11.52M |
| Short % of Shares Out | 22.94% |
| Short % of Float | 30.87% |
| Short Ratio (days to cover) | 16.77 |
Income Statement
In the last 12 months, FDMT had revenue of $88.24 million and -$160.90 million in losses. Loss per share was -$2.64.
| Revenue | 88.24M |
| Gross Profit | -128.54M |
| Operating Income | -176.35M |
| Pretax Income | -160.90M |
| Net Income | -160.90M |
| EBITDA | -171.43M |
| EBIT | -176.35M |
| Loss Per Share | -$2.64 |
Full Income StatementBalance Sheet
The company has $390.89 million in cash and $20.54 million in debt, with a net cash position of $437.10 million or $8.36 per share.
| Cash & Cash Equivalents | 390.89M |
| Total Debt | 20.54M |
| Net Cash | 437.10M |
| Net Cash Per Share | $8.36 |
| Equity (Book Value) | 451.84M |
| Book Value Per Share | 8.64 |
| Working Capital | 361.96M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$129.45 million and capital expenditures $95,000, giving a free cash flow of -$129.35 million.
| Operating Cash Flow | -129.45M |
| Capital Expenditures | 95,000 |
| Depreciation & Amortization | 4.91M |
| Net Borrowing | n/a |
| Free Cash Flow | -129.35M |
| FCF Per Share | -$2.47 |
Full Cash Flow StatementMargins
Gross margin is -145.66%, with operating and profit margins of -199.84% and -182.34%.
| Gross Margin | -145.66% |
| Operating Margin | -199.84% |
| Pretax Margin | -182.34% |
| Profit Margin | -182.34% |
| EBITDA Margin | -194.28% |
| EBIT Margin | -199.84% |
| FCF Margin | n/a |
Dividends & Yields
FDMT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.81% |
| Shareholder Yield | -9.81% |
| Earnings Yield | -35.79% |
| FCF Yield | -28.77% |
Analyst Forecast
The average price target for FDMT is $28.22, which is 228.14% higher than the current price. The consensus rating is "Buy".
| Price Target | $28.22 |
| Price Target Difference | 228.14% |
| Analyst Consensus | Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (5Y) | 40.05% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
FDMT has an Altman Z-Score of 1.26 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.26 |
| Piotroski F-Score | 2 |
